Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)
National Institutes of Health · PAR-25-145 · Research funding opportunity
Overview
Supports collaborative studies of persistent or delayed adverse effects of cancer treatment. Research may identify underlying mechanisms, characterise long-term clinical effects or develop approaches to prevent or reduce treatment-related complications.
Eligibility
Wits may apply as a non-US higher education institution. Proposals must fit this call and the mission of a participating institute; institutional registrations and funder requirements apply.
Other deadlines
Next new-application deadline: 5 October 2026. Next renewal/resubmission/revision deadline, where permitted: 5 November 2026. Submit by 17:00 local time of the applicant organisation. Call expiration: 8 January 2028. This is separate from the application deadline.